Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
VESTLANDETS INNOVASJONSSELSKAP AS manages a company patent portfolio within the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 2 pending office actions distributed across 2 distinct examiners. This distribution shows that each examiner is currently managing 1 action for the company. Prosecution is occurring across 2 distinct art units, reflecting a breadth of technical review within the biotechnology sector.
BERRY, LAYLA D is identified as the busiest examiner with 1 pending office action. With 2 pending office actions in total, the workload is distributed such that each of the 2 distinct examiners is assigned to 1 pending office action. The presence of 2 distinct art units suggests that the pending applications cover different specialized areas of biotechnology. This decentralized approach ensures that each of the 2 pending office actions receives a dedicated review from a different examiner, potentially leading to varied prosecution timelines across the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BERRY, LAYLA D | 1 | 66.0% | +9.0% |
| BAEK, JONGHWAN NMN | 1 | 60.0% | +0.0% |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18573963 | NAD-AUGMENTATION THERAPY FOR PARKINSON'S DISEASE | BERRY, LAYLA D | 1693 | §102§103§112DP | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18255557 | IMAGING METHODS AND RADIOTRACERS FOR USE THEREIN | BAEK, JONGHWAN NMN | 1618 | §103 | Final Rejection | 15d overdue | Pending | Jun 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial